Compare STOK & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | WB |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2019 | 2014 |
| Metric | STOK | WB |
|---|---|---|
| Price | $26.13 | $6.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | ★ $46.46 | $8.24 |
| AVG Volume (30 Days) | 638.1K | ★ 883.9K |
| Earning Date | 11-03-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 9.44% |
| EPS Growth | ★ 92.73 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $184,420,000.00 | N/A |
| Revenue This Year | N/A | $0.11 |
| Revenue Next Year | $39.98 | $0.78 |
| P/E Ratio | ★ N/A | $5.66 |
| Revenue Growth | ★ 404.50 | N/A |
| 52 Week Low | $20.32 | $6.37 |
| 52 Week High | $40.22 | $12.77 |
| Indicator | STOK | WB |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 32.11 |
| Support Level | $25.21 | N/A |
| Resistance Level | $33.92 | $6.79 |
| Average True Range (ATR) | 1.15 | 0.10 |
| MACD | -0.17 | 0.02 |
| Stochastic Oscillator | 36.31 | 25.00 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.